RESUMO
Cerebral malaria (CM) is a severe immunovasculopathy which presents high mortality rate (15-20%), despite the availability of artemisinin-based therapy. More effective immunomodulatory and/or antiparasitic therapies are urgently needed. Experimental Cerebral Malaria (ECM) in mice is used to elucidate aspects involved in this pathology since manifests many of the neurological features of CM. In the present study, we evaluated the potential mechanisms involved in the protection afforded by perillyl alcohol (POH) in mouse strains susceptible to CM caused by Plasmodium berghei ANKA (PbA) infection through intranasal preventive treatment. Additionally, to evaluate the interaction of POH with the cerebral endothelium using an in vitro model of human brain endothelial cells (HBEC). Pharmacokinetic approaches demonstrated constant and prolonged levels of POH in the plasma and brain after a single intranasal dose. Treatment with POH effectively prevented vascular dysfunction. Furthermore, treatment with POH reduced the endothelial cell permeability and PbA s in the brain and spleen. Finally, POH treatment decreased the accumulation of macrophages and T and B cells in the spleen and downregulated the expression of endothelial adhesion molecules (ICAM-1, VCAM-1, and CD36) in the brain. POH is a potent monoterpene that prevents cerebrovascular dysfunction in vivo and in vitro, decreases parasite sequestration, and modulates different processes related to the activation, permeability, and integrity of the blood brain barrier (BBB), thereby preventing cerebral oedema and inflammatory infiltrates.
RESUMO
BACKGROUND: Cerebral malaria (CM) is a severe immunovasculopathy caused for Plasmodium falciparum infection, which is characterised by the sequestration of parasitised red blood cells (pRBCs) in brain microvessels. Previous studies have shown that some terpenes, such as perillyl alcohol (POH), exhibit a marked efficacy in preventing cerebrovascular inflammation, breakdown of the brain-blood barrier (BBB) and brain leucocyte accumulation in experimental CM models. OBJECTIVE: To analyse the effects of POH on the endothelium using human brain endothelial cell (HBEC) monolayers co-cultured with pRBCs. METHODOLOGY: The loss of tight junction proteins (TJPs) and features of endothelial activation, such as ICAM-1 and VCAM-1 expression were evaluated by quantitative immunofluorescence. Microvesicle (MV) release by HBEC upon stimulation by P. falciparum was evaluated by flow cytometry. Finally, the capacity of POH to revert P. falciparum-induced HBEC monolayer permeability was examined by monitoring trans-endothelial electrical resistance (TEER). FINDINGS: POH significantly prevented pRBCs-induced endothelial adhesion molecule (ICAM-1, VCAM-1) upregulation and MV release by HBEC, improved their trans-endothelial resistance, and restored their distribution of TJPs such as VE-cadherin, Occludin, and JAM-A. CONCLUSIONS: POH is a potent monoterpene that is efficient in preventing P. falciparum-pRBCs-induced changes in HBEC, namely their activation, increased permeability and alterations of integrity, all parameters of relevance to CM pathogenesis.
Assuntos
Malária Cerebral , Malária Falciparum , Humanos , Plasmodium falciparum , Molécula 1 de Adesão Intercelular/metabolismo , Células Endoteliais , Molécula 1 de Adesão de Célula Vascular/metabolismo , Encéfalo/metabolismo , Encéfalo/patologia , Malária Cerebral/metabolismo , Malária Cerebral/patologia , Monoterpenos/metabolismo , Barreira Hematoencefálica/metabolismo , Barreira Hematoencefálica/patologia , Endotélio Vascular , PermeabilidadeRESUMO
BACKGROUND: Antimicrobial stewardship programs (ASPs) have become a fundamental pillar in optimizing antimicrobial usage, improving patient care, and reducing antimicrobial resistance (AMR). Herein we evaluated the impact of an ASP on antimicrobial consumption and AMR in Colombia. METHODS: We designed a retrospective observational study and measured trends in antibiotic consumption and AMR before and after the implementation of an ASP using interrupted time series analysis over a 4-year period (24 months before and 24 months after ASP implementation). RESULTS: ASPs were implemented according to the available resources in each of the institutions. Before ASP implementation, there was a trend toward an increase in the antibiotic consumption of all measured antimicrobials selected. Afterward, an overall decrease in antibiotic consumption was observed. The use of ertapenem and meropenem decreased in hospital wards, while a decrease in the use of ceftriaxone, cefepime, piperacillin/tazobactam, meropenem, and vancomycin was observed in intensive care units. After ASP implementation, the trend toward an increase of oxacillin-resistant Staphylococcus aureus, ceftriaxone-resistant Escherichia coli, and meropenem-resistant Pseudomonas aeruginosa was reversed. CONCLUSIONS: In our study, we showed that ASPs are a key strategy in tackling the emerging threat of AMR and have a positive impact on antibiotic consumption and resistance.
Assuntos
Anti-Infecciosos , Gestão de Antimicrobianos , Staphylococcus aureus Resistente à Meticilina , Antibacterianos/uso terapêutico , Ceftriaxona , Colômbia , Atenção à Saúde , Farmacorresistência Bacteriana , Humanos , Meropeném/uso terapêuticoRESUMO
Candida auris is an emerging multidrug-resistant fungus that causes hospital-associated outbreaks of invasive infections with high death rates. During 2015-2016, health authorities in Colombia detected an outbreak of C. auris. We conducted an investigation to characterize the epidemiology, transmission mechanisms, and reservoirs of this organism. We investigated 4 hospitals with confirmed cases of C. auris candidemia in 3 cities in Colombia. We abstracted medical records and collected swabs from contemporaneously hospitalized patients to assess for skin colonization. We identified 40 cases; median patient age was 23 years (IQR 4 months-56 years). Twelve (30%) patients were <1 year of age, and 24 (60%) were male. The 30-day mortality was 43%. Cases clustered in time and location; axilla and groin were the most commonly colonized sites. Temporal and spatial clustering of cases and skin colonization suggest person-to-person transmission of C. auris. These cases highlight the importance of adherence to infection control recommendations.
Assuntos
Candida , Candidíase/epidemiologia , Candidíase/microbiologia , Doenças Transmissíveis Emergentes/epidemiologia , Doenças Transmissíveis Emergentes/microbiologia , Infecção Hospitalar , Surtos de Doenças , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Antifúngicos/farmacologia , Antifúngicos/uso terapêutico , Candida/efeitos dos fármacos , Candidemia/epidemiologia , Candidemia/microbiologia , Candidíase/tratamento farmacológico , Candidíase/história , Criança , Pré-Escolar , Colômbia/epidemiologia , Doenças Transmissíveis Emergentes/história , Farmacorresistência Fúngica , Feminino , História do Século XXI , Humanos , Lactente , Masculino , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Mortalidade , Avaliação de Resultados da Assistência ao Paciente , Vigilância em Saúde Pública , Estações do Ano , Adulto JovemRESUMO
BACKGROUND: Candida auris is an emerging MDR pathogen. It shows reduced susceptibility to azole drugs and, in some strains, high amphotericin B MICs have been described. For these reasons, echinocandins were proposed as first-line treatment for C. auris infections. However, information on how echinocandins and amphotericin B act against this species is lacking. OBJECTIVES: Our aim was to establish the killing kinetics of anidulafungin, caspofungin and amphotericin B against C. auris by time-kill methodology and to determine if these antifungals behave as fungicidal or fungistatic agents against this species. METHODS: The susceptibility of 50 C. auris strains was studied. Nine strains were selected (based on echinocandin MICs) to be further studied. Minimal fungicidal concentrations, in vitro dose-response and time-kill patterns were determined. RESULTS: Echinocandins showed lower MIC values than amphotericin B (geometric mean of 0.12 and 0.94 mg/L, respectively). Anidulafungin and caspofungin showed no fungicidal activity at any concentration (maximum log decreases in cfu/mL between 1.34 and 2.22). On the other hand, amphotericin B showed fungicidal activity, but at high concentrations (≥2.00 mg/L). In addition, the tested polyene was faster than echinocandins at killing 50% of the initial inoculum (0.92 versus >8.00 h, respectively). CONCLUSIONS: Amphotericin B was the only agent regarded as fungicidal against C. auris. Moreover, C. auris should be considered tolerant to caspofungin and anidulafungin considering that their MFC:MIC ratios were mostly ≥32 and that after 6 h of incubation the starting inoculum was not reduced in >90%.
Assuntos
Anfotericina B/farmacologia , Anidulafungina/farmacologia , Antifúngicos/farmacologia , Candida/efeitos dos fármacos , Caspofungina/farmacologia , Viabilidade Microbiana/efeitos dos fármacos , Testes de Sensibilidade Microbiana , Fatores de TempoRESUMO
As part of ongoing efforts to isolate biologically active fungal metabolites, a cyclic pentapeptide, sheptide A (1), was discovered from strain MSX53339 (Herpotrichiellaceae). The structure and sequence of 1 were determined primarily by analysis of 2D NMR and HRMS/MS data, while the absolute configuration was assigned using a modified version of Marfey's method. In an in vitro assay for antimalarial potency, 1 displayed a pEC50 value of 5.75 ± 0.49 against malaria-causing Plasmodium falciparum. Compound 1 was also tested in a counter screen for general cytotoxicity against human hepatocellular carcinoma (HepG2), yielding a pCC50 value of 5.01 ± 0.45 and indicating a selectivity factor of ~6. This makes 1 the third known cyclic pentapeptide biosynthesized by fungi with antimalarial activity.
Assuntos
Antimaláricos , Ascomicetos , Malária , Humanos , Antimaláricos/química , Malária/tratamento farmacológico , Plasmodium falciparum , Extratos Vegetais/químicaRESUMO
Rheumatoid arthritis (RA) is a chronic autoimmune disease which is characterized primarily by synovial hyperplasia and accumulation of several types of immune infiltrates that promote progressive destruction of the articular structure. Glucocorticoids are often prescribed to treat RA because of their strong anti-inflammatory and immunosuppressive effects. However, their application must be limited to the short-term due to a risk of adverse events. In the present study, we examined the potential combination of low-dose prednisone with gene delivery of an agent of promising and complementary effectiveness in RA, interleukin (IL)-27. IL-27 has been shown to have anti-inflammatory potential, while also acting as an effective bone-normalization agent in prior reports. The present report examined a version of IL-27 targeted at the C-terminus with a short 'peptide L' (pepL, LSLITRL) that binds the interleukin 6 receptor α (IL-6Rα) upregulated during inflammation. By focusing on this targeted form, IL-27pepL or 27pL, we examined whether the anti-inflammatory potential of prednisone (at a relatively low dose and short duration) could be further enhanced in the presence of 27pL as a therapy adjuvant. Our results indicate that 27pL represents a novel tool for use as an adjuvant with current therapeutics, such as prednisone, against inflammatory conditions.
RESUMO
We report the emergence of a novel VIM variant (VIM-24) in a Klebsiella pneumoniae isolate in Colombia. The isolate displays MICs for carbapenems below the resistance breakpoints, posing a real challenge for its detection. The blaVIM-24 gene was located within a class 1 integron carried on a large plasmid. Further studies are needed to clarify its epidemiological and clinical impact.
Assuntos
Klebsiella pneumoniae/efeitos dos fármacos , Klebsiella pneumoniae/enzimologia , beta-Lactamases/metabolismo , Antibacterianos/farmacologia , Colômbia , Farmacorresistência Bacteriana Múltipla/genética , Integrons/genética , Klebsiella pneumoniae/genética , Testes de Sensibilidade Microbiana , Plasmídeos/química , beta-Lactamases/genéticaRESUMO
BACKGROUND: Candida auris is an emerging multidrug-resistant yeast that can cause invasive infections and healthcare-associated outbreaks. Here, we describe 34 cases of pediatric C. auris bloodstream infections (BSIs) identified during July 2014-October 2017 in 2 hospitals in Colombia. METHODS: We conducted a retrospective review of microbiology records for possible C. auris cases in 2 hospitals in Barranquilla and Cartagena. BSIs that occurred in patients aged <18 years confirmed as C. auris were included in this analysis. RESULTS: We identified 34 children with C. auris BSIs. Twenty-two (65%) patients were male, 21% were aged <28 days, 47% were aged 29-365 days, and 32% were aged >1 year. Underlying conditions included preterm birth (26%), being malnourished (59%), cancer (12%), solid-organ transplant (3%), and renal disease (3%). Eighty-two percent had a central venous catheter (CVC), 82% were on respiratory support, 56% received total parenteral nutrition (TPN), 15% had a surgical procedure, and 9% received hemodialysis. Preinfection inpatient stay was 22 days (interquartile range, 19-33 days), and in-hospital mortality was 41%. CONCLUSIONS: Candida auris affects children with a variety of medical conditions including prematurity and malignancy, as well as children with CVCs and those who receive TPN. Mortality was high, with nearly half of patients dying before discharge. However, unlike most other Candida species, C. auris can be transmitted in healthcare settings, as suggested by the close clustering of cases in time at each of the hospitals.Candida auris is an emerging multidrug-resistant yeast that can cause invasive infections and healthcare-associated outbreaks. This report describes 34 cases of pediatric C. auris bloodstream infections, identified in two hospitals in Colombia, South America.
Assuntos
Candidíase Invasiva , Nascimento Prematuro , Sepse , Antifúngicos/uso terapêutico , Candida , Candidíase Invasiva/tratamento farmacológico , Criança , Colômbia/epidemiologia , Feminino , Humanos , Recém-Nascido , Masculino , Testes de Sensibilidade Microbiana , Gravidez , Nascimento Prematuro/tratamento farmacológico , Estudos Retrospectivos , Sepse/tratamento farmacológicoRESUMO
Introducción: Klebsiella rhinoscleromatis (KR) es una enterobacteria asociada con formación de granulomatosis crónica. Cuando este microorganismo afecta el tracto respiratorio se denomina escleroma, afectando principalmente la cavidad nasal; puede comprometer nasofaringe, laringe, tráquea y bronquios. Caso clínico: paciente femenina con antecedente de laringotraqueítis crónica con diagnóstico de estenosis traqueal y aislamiento en cultivos de Klebsiella pneumoniae ssp rhinoscleromatis multisensible, sin compromiso nasosinusal o extralaríngeo. Discusión: el escleroma puede afectar todo el tracto respiratorio y se deben tener presentes factores de riesgo asociados, como condiciones de hacinamiento, inmunosupresión y sexo femenino. El pilar del tratamiento es médico, basado en antibióticos; adicionalmente, se reserva manejo quirúrgico en la etapa esclerótica, donde hay ausencia del fenómeno inflamatorio. Conclusión: el escleroma es una patología rara con una evolución crónica y compromiso principalmente en cavidad nasal, que requiere alta sospecha diagnóstica para realizar manejo oportuno.
Introduction: Klebsiella rhinoscleromatis (KR) is an enterobacterium associated with the formation of chronic granulomatosis. When this microorganism affects the respiratory tract, it is called scleroma, the nasal cavity is the main one affected; additionally, it can involve nasopharynx, larynx, trachea, and bronchi. Clinical case: female patient with a history of chronic laryngotracheitis, with diagnosis of tra-cheal stenosis and isolation in cultures of multisensitive Klebsiella pneumoniae ssp rhinoscleromatis, without nasosinusal or extralaryngeal involvement. Discussion: scleroma can affect the entire respiratory tract, so associated risk factors should be taken into account, mainly overcrowding, immunosuppression, and female sex, in whom it is more common. The mainstay of treatment is medical, based on antibio-tics; additionally, surgical management is reserved for sclerotic stage, when there is no inflammatory phenomenon. Conclusion: scleroma is a rare pathology, with a chronic evolution, with involvement mainly in the nasal cavity, which requires a high diagnostic suspicion for its timely management.
Assuntos
Humanos , Masculino , FemininoRESUMO
Resumen Introducción: Poco se conoce del potencial dendrocronológico de las Podocarpáceas en el trópico. Objetivo: Explorar el potencial dendrocronológico de tres especies de podocarpáceas: Retrophyllum rospigliosii, Podocarpus oleifolius y Prumnopitys harmsiana. Métodos: De plantaciones no manejadas localizadas en los Andes colombianos, se muestrearon y analizaron 88 árboles: 30 muestras de R. rospigliosii provenientes de secciones transversales, 30 y 28 muestras de P. oleifolius y P. harmsiana, respectivamente, provenientes de núcleos de madera extraídos con barreno de incrementos. Las muestras se procesaron siguiendo las técnicas dendrocronológicas estándar. Resultados: En general, las características anatómicas de los anillos de crecimiento son similares para las tres especies, con una anatomía simple de traqueidas alineadas radialmente por tratarse de coníferas. Dado que la edad conocida de la plantación coincide con el número de anillos se considera una fuerte evidencia de la frecuencia anual de su formación en R. rospigliosii y P. oleifolius, las cuales presentaron buena sincronización (cofechado) con una inter-correlación promedio de 0.55 (r-Pearson). Para P. harmsiana no fue posible concretar series de ancho de anillos de las muestras recolectadas. Las series estandarizadas de R. rospigliosii y P. oleifolius mostraron una relación con los registros instrumentales de precipitación y temperatura, indicando que estas especies pueden ser promisorias para estudios adicionales. Conclusión: La investigación dendrocronología con especies de Podocarpáceas podría realizarse exitosamente con R. rospigliosii y P. oleifolius, pero no con P. harmsiana.
Abstract Introduction: Little is known about the dendrochronological potential of Podocarpaceaes in the tropics. Objective: To explore the dendrochronological potential of three Podocarpaceae species: Retrophyllum rospigliosii, Podocarpus oleifolius, and Prumnopitys harmsiana. Methods: From a non-managed plantation in the Andean cordillera in Colombia, a total of 88 trees were analyzed: 30 samples of cross-sections of R. rospigliosii, and 30 and 28 samples of P. oleifolius and P. harmsiana, respectively, obtained with an increment borer. Samples were processed according to standard dendrochronological methods. Results: The anatomical characteristics of the growth rings of the three species are similar, with a simple conifer anatomy with radially oriented tracheids. Since the known age of the plantation coincides with the number of tree rings this is strong evidence of annual tree-ring frequency of R. rospigliosii and P. oleifolius which also showed a satisfactory cross-dating with an average inter-correlation of 0.55 (r-Pearson). For P. harmsiana, it was not possible to build a tree-ring series from the collected samples. R. rospigliosii and P. oleifolius standardized ring-width chronologies showed a relationship with the instrumental records of rainfall and temperature, indicating these species may be promising further studies. Conclusions: Dendrochronological research with Podocarpaceae species could be carried out successfully with R. rospigliosii and P. oleifolius but not with P. harmsiana.
Assuntos
Desenvolvimento Vegetal/fisiologia , Traqueófitas/crescimento & desenvolvimento , Senescência Vegetal/fisiologia , Árvores/crescimento & desenvolvimento , Colômbia , Crescimento e DesenvolvimentoRESUMO
BACKGROUND: Candida auris and Candida haemulonii are emerging and multiresistant pathogens. C. auris has produced hospital outbreaks and is misidentified by phenotypic-based methods. The only reliable identification methods are DNA sequencing and MALDI-TOF. AIMS: To develop a classical-PCR method capable of rapidly and accurately identify C. auris and C. haemulonii. METHODS: A multiplex PCR was carried out in one tube that included an internal control and oligonucleotides that specifically hybridize to the ITS2 region of C. auris and C. haemulonii. The usefulness of the new method was verified by testing a collection of 50 strains of 20 different species (previously identified by ITS sequencing). The selection of species was made in order to emulate the C. auris panel used by the CDC to validate diagnostic tools. In addition, other yeast species not included in the aforementioned panel were incorporated based on reported identification errors. RESULTS: The results obtained with the proposed protocol were in total agreement with those obtained by ITS sequencing. CONCLUSIONS: We present a PCR method able to unequivocally identify C. auris and differentiate it from C. haemulonii. It is inexpensive, fast and it could be a useful tool to reduce the chances of a C. auris outbreak.
Assuntos
Candida/classificação , Reação em Cadeia da Polimerase Multiplex/métodos , Técnicas de Tipagem Micológica/métodos , Sequência de Bases , Candida/genética , Candidíase/microbiologia , Doenças Transmissíveis Emergentes/microbiologia , Primers do DNA , DNA Fúngico/genética , DNA Espaçador Ribossômico/genética , Humanos , Reação em Cadeia da Polimerase Multiplex/instrumentação , Análise de Sequência de DNA , Especificidade da Espécie , Leveduras/genéticaRESUMO
BACKGROUND Cerebral malaria (CM) is a severe immunovasculopathy caused for Plasmodium falciparum infection, which is characterised by the sequestration of parasitised red blood cells (pRBCs) in brain microvessels. Previous studies have shown that some terpenes, such as perillyl alcohol (POH), exhibit a marked efficacy in preventing cerebrovascular inflammation, breakdown of the brain-blood barrier (BBB) and brain leucocyte accumulation in experimental CM models. OBJECTIVE To analyse the effects of POH on the endothelium using human brain endothelial cell (HBEC) monolayers co-cultured with pRBCs. METHODOLOGY The loss of tight junction proteins (TJPs) and features of endothelial activation, such as ICAM-1 and VCAM-1 expression were evaluated by quantitative immunofluorescence. Microvesicle (MV) release by HBEC upon stimulation by P. falciparum was evaluated by flow cytometry. Finally, the capacity of POH to revert P. falciparum-induced HBEC monolayer permeability was examined by monitoring trans-endothelial electrical resistance (TEER). FINDINGS POH significantly prevented pRBCs-induced endothelial adhesion molecule (ICAM-1, VCAM-1) upregulation and MV release by HBEC, improved their trans-endothelial resistance, and restored their distribution of TJPs such as VE-cadherin, Occludin, and JAM-A. CONCLUSIONS POH is a potent monoterpene that is efficient in preventing P. falciparum-pRBCs-induced changes in HBEC, namely their activation, increased permeability and alterations of integrity, all parameters of relevance to CM pathogenesis.
RESUMO
Introducción: las infecciones profundas del cuello son patologías complejas con gran potencial de complicaciones graves, que, debido a su ubicación pueden ser de difícil reconocimiento y manejo. Es de gran importancia realizar un diagnóstico asertivo y ofrecer el tratamiento adecuado para poder disminuir las complicaciones que se pudieran presentar. La ecografía es una ayuda diagnóstica cada vez más utilizada que nos puede ayudar a guiar nuestras conductas de manera rápida y efectiva. Caso clínico: presentamos un caso de un paciente con un absceso en cuello, en el que la utilización de la ecografía de manera intraoperatoria facilitó la toma de decisiones y evitó procedimientos invasivos innecesarios. Conclusiones: el Point of Care Ultrasound (PoCUS) es una forma rápida y práctica de resolver preguntas y facilitar la toma de decisiones objetivas en el entorno perioperatorio.
Introduction: Deep neck infections are a complex group of pathologies with great potential for serious complications due to their location. Therefore, recognition and management can be a challenge. To reduce the risk of complications it is extremely important to have an assertive diagnosis y and offer the proper treatment. An ultrasound is a diagnosis tool that is being used more often because it can help us guide our medical decisions in a quick and effective way. Clinical case: We present a case of a patient who had an intraoperative ultrasound which helped in the decision making and avoided any further invasive procedures. Conclusions: The Point of Care Ultrasound (PoCUS) is a quick and practical way to solve questions and facilitate objective decisions in the perioperative environment.
Assuntos
Humanos , Masculino , Feminino , Manuseio das Vias Aéreas , Pescoço , Relatos de Casos , Ultrassonografia , AbscessoRESUMO
La leishmaniasis es una enfermedad protozoaria intracelular. Una de sus formas de presentación es la mucocutánea, que es secuela de la leishmania cutánea y solo se presenta en el 1 % al 5 % de quienes la padecen. Afecta la mucosa nasal, faríngea y laríngea, lo que ocasiona disnea y disfagia. Se presenta el caso de una paciente de 76 años con síntomas obstructivos nasales, en quien se evidenciaron múltiples sinequias nasales y faringolaríngeas. Ante la sospecha clínica de la enfermedad, es importante recordar que el diagnóstico se realiza a través de la intradermorreacción de Montenegro o títulos de inmunofluorescencia indirecta superiores a 1:16, y su tratamiento incluye el antimonio pentavalente, uno de los más utilizados; sin embargo, este tiene alto grado de recurrencias y efectos secundarios, por lo que la anfotericina B se convierte en el tratamiento de elección. En algunos casos, el manejo quirúrgico puede ser de gran utilidad para la mejoría de síntomas y secuelas de la enfermedad. Entonces, la leishmania mucocutánea se convierte en una enfermedad de interés para los otorrinolaringólogos, quienes con el conocimiento de la historia natural de la misma pueden realizar un manejo temprano y la adecuada corrección de secuelas para mejorar la calidad de vida de los pacientes.
Leishmaniasis is an intracellular protozoan disease. One of its forms of presentation is mucocutaneous, which is sequela of cutaneous leishmania and only occurs in 1% to 5% of those who suffer it. It affects the nasal, pharyngeal and laryngeal mucosa, causing dyspnea and dysphagia. We presented a case of a 76-year-old patient with obstructive nasal symptoms, who evidenced multiple nasal and pharyngolaryngeal synechiae. Given the clinical suspicion of the disease, it is important to remember that the diagnosis is made through the Montenegro intradermal reaction and or indirect immunofluorescence titers greater than 1:16, and the treatment includes pentavalent antimonial, one of the most used; however, it has a high degree of recurrence and side effects, so amphotericin B becomes the treatment of choice. In some cases, surgical management can be very useful for the improvement of symptoms caused by the disease. Thus, mucocutaneous leishmania becomes a disease of interest for otorhinolaryngologists, who, with knowledge of its natural history, can carry out early management and adequate correction of sequelae to improve the patients' quality of life.
Assuntos
Humanos , Leishmaniose , Terapêutica , Diagnóstico , MucosaRESUMO
The renal resistive index (RRI) measured by Doppler sonography is a marker of microvascular status that can be generalized to the whole of the arterial tree. Its association with large-vessel dysfunction, such as arterial stiffness or the atherosclerotic burden, can help to establish physiopathological associations between macrocirculation and microcirculation. The authors conducted a cross-sectional study of hypertensive patients (n=202) and a healthy control group (n=16). Stiffness parameters, atherosclerotic burden, and determination of the RRI in both kidneys were performed. The average RRI was 0.69±0.08 and was significantly greater in patients with diabetes and chronic kidney disease. Renal resistive index positively correlated with age, creatinine, and albuminuria. Positive correlations were found with arterial stiffness parameters (pulse wave velocity, ambulatory arterial stiffness index, and 24-hour pulse pressure), as well as atherosclerotic burden and endothelial dysfunction measured as asymmetric dimethylarginine in serum. In the multivariate analysis, independent factors for increased RRI were age, renal function, 24-hour diastolic blood pressure, and arterial stiffness. The authors concluded that there is an independent association between renal hemodynamics and arterial stiffness. This, together with the atherosclerotic burden and endothelial dysfunction, suggests that there is a physiopathologic relationship between macrovascular and microvascular impairment.
Assuntos
Aterosclerose/fisiopatologia , Circulação Sanguínea/fisiologia , Rim/irrigação sanguínea , Microcirculação/fisiologia , Artéria Renal/fisiologia , Resistência Vascular/fisiologia , Rigidez Vascular/fisiologia , Adulto , Fatores Etários , Idoso , Aterosclerose/epidemiologia , Pressão Sanguínea/fisiologia , Estudos de Casos e Controles , Estudos Transversais , Diabetes Mellitus/fisiopatologia , Endotélio Vascular/fisiopatologia , Feminino , Humanos , Hipertensão/fisiopatologia , Incidência , Rim/fisiologia , Rim/fisiopatologia , Masculino , Pessoa de Meia-Idade , Artéria Renal/diagnóstico por imagem , Artéria Renal/fisiopatologia , Insuficiência Renal Crônica/fisiopatologia , Ultrassonografia DopplerRESUMO
La actinomicosis es una enfermedad supurativa crónica causada por Actinomyces israelii, este es un saprófito de la cavidad oral, criptas amígdalinas y el tracto gastrointestinal en un 30% de sujetos sanos. Es una enfermedad poco frecuente con una incidencia de 5/100 000. La mayoría de las veces se presenta como una complicación por el uso de bifosfona-tos o inmunosupresión como malignidad o diabetes mellitus y, raramente, por procedi-mientos orales.
Actinomycosis is a chronic suppurative disease caused by Actinomyces israelii, this is a saprophyte of the oral cavity, amygdaline crypts and the gastrointestinal tract in 30% of healthy subjects. It is a rare disease with an incidence of 5 / 100,000. Most of the time it presents as a complication to the use of bisphosphonates or immunosuppression as ma-lignancy or diabetes mellitus and rarely to oral procedures.
Assuntos
Humanos , Actinomicose Cervicofacial , Síndromes da Apneia do SonoRESUMO
En 2010, el Instituto Americano de Estándares Clínicos y de Laboratorio (CLSI) inició un proceso de revisión y actualización de los puntos de corte para microdilución y disco difusión para cefalosporinas (cefazolina, cefotaxima, ceftriaxona, ceftizoxima, ceftazidima), monobactámicos (aztreonam) y carbapenémicos (imipenem, meropenem, ertapenem, doripenem). Los cambios se basaron en modelos PK/PD que buscan predecir la respuesta clínica con el uso exclusivo de la concentración inhibitoria mínima (CIM) y esquemas específicos de dosificación de forma independiente al mecanismo de resistencia expresado. Este nuevo paradigma eliminaría la necesidad de realizar pruebas fenotípicas para beta-lactamasas de espectro extendido (BLEE) y carbapenemasas para tomar decisiones terapéuticas y permitiría utilizarlas únicamente para fines epidemiológicos. Sin embargo, ante las limitaciones de las metodologías actuales para pruebas de susceptibilidad en Colombia, el desconocimiento de estos cambios y la alarma epidemiológica por la aparición de nuevas ß-lactamasas en el país, se hace necesario generar recomendaciones para los laboratorios clínicos, con el fi n de unifi car los criterios para la realización e informe de los antibiogramas en bacilos Gram negativos, incluyendo la implementación de los puntos de corte actuales y la aplicación de las pruebas fenotípicas para la detección de BLEE y carbapenemasas.
In 2010, the Clinical and Laboratory Standards Institute (CLSI) began a process to revise and update the breakpoints for broth microdilution and disk diffusion for cephalosporins (Cefazolin, Cefotaxime, Ceftriaxone, Ceftazidime), monobactams (Aztreonam) and carbapenems (Imipenem, Meropenem, Ertapenem and Doripenem). The changes made were based on PK/PD models that attempt to predict clinical outcomes using minimum inhibitory concentration (MIC) and specific dosage regimens, regardless of the resistance mechanism expressed by the organism. The new breakpoints would eliminate the need to perform screening and confirmatory testing for ESBLs and carbapenemases for treatment decisions, and thus they would be used only for infection control purposes. Nevertheless, there are limitations to current methods in Colombia, a lack of knowledge regarding the recent changes and epidemiologic alarm over new B-lactamases spreading in our country. Therefore it was necessary to formulate and issue recommendations for clinical laboratories, with the aim of standardizing the criteria for reports on antibiograms in Gram-negative bacilli, including the current CLSI breakpoints and applying phenotypic confirmatory testing to detect ESBLs and Carbapenemases.
Assuntos
Humanos , beta-Lactamases , Cefalosporinas , Epidemiologia , Colômbia , Enzimas , Serviços de Laboratório ClínicoRESUMO
Se realizo un estudio prospectivo para determinar y analizar la incidencia de infeccion de la herida quirurgica segun el tipo de cirugia en el Hospital Regional Simon Bolivar de Bogota, desde febrero de 1985 hasta Agosto de 1986. Se revisaron 278 intervenciones quirurgicas seleccionadas de una poblacion de pacientes de cirugia general. La tasa de infeccion segun el tipo de cirugia fue de 3.06% para las limpias, 9.09% para las limpias contaminadas, 14.6% para las contaminadas y 30% para las cirugias sucias. Los resultados fueron comparados con series nacionales e internacionales, encontrandose similitud en los porcentajes de cada categoria.